News

On behalf of his co-authors, BHF Professor Martin Bennett received the John Shillingford Award at the 2026 ESC Congress. The award recognises the top original research article published in the journal Cardiovascular Research in 2025. The research bridges the gap between discovery and the clinic, offering new insights into how damaged cells in blood…

Congratulations to Mike Murphy, who delivered the Keith Reimer Distinguished Lecture of the International Society for Heart Research (ISHR) at the 39th Annual meeting of the Society’s European Section, held in Birmingham.Keith Reimer was a leader in the study of myocardial ischemia, and for 25 years moved that field forward in many important ways, …

Mitochondrial lipid peroxidation is central to cell death by ferroptosis in many pathologies including cardiovascular disease. However, measuring this process is challenging. As part of a Wellcome Trust-funded collaboration led by Mike Murphy at the MRC Mitochondrial Biology Unit and Richard Hartley at Glasgow, this has been addressed by developing…

A major international coalition co-led by the University of Cambridge and Stanford Medicine has secured a grant of $9 million (approximately £6.7 million) to develop new approaches for predicting and preventing heart attacks and strokes.The European Coordinator for the multi-centre network will be Dr Helle F Jørgensen, Associate Professor within th…

Many congratulations to Sarah Teichmann from the Stem Cell Institute  who has been named one of the five international laureates of the 2026 L’Oréal–UNESCO For Women in Science International Awards. Sarah is the laureate for Europe and has been recognised for her outstanding interdisciplinary research, using genome science and computational biology…

Aaliyah Razi, of Gonville & Caius College, has honoured at last month’s international annual meeting of the Society for Reproductive Investigation (SRI), held in San Juan, Puerto Rico, March 24-28, 2026.Aaliyah received an award for one of the top 10 scoring abstracts from 1200 submitted. Her work was entitled ‘miR-21-5p Rescues Peripheral Vascular…

Heart failure is becoming increasingly common and places a major strain on people’s lives and on health systems. Many cases could potentially be prevented if we could better identify who is at higher risk early enough. This paper describes the development of SCORE2-HF, a new tool to estimate a person’s chance of developing heart failure (HF) over t…

Researchers from the Cambridge Cardiovascular network and their collaborators have created a system called CytoDiffusion that uses generative AI to study the shape and structure of blood cells. A tool that can analyse abnormalities in the shape and form of blood cells with greater accuracy and reliability than human experts could change the way som…

One of four innovative projects from Cambridge University, funded by a new scheme from UKRI to translate academic impact into practical solutions for global impact, will focus on AI-Based Coronary Artery Analysis. The funded project, led by Prof Martin Bennett of the Department of Medicine, will aim to improve the accuracy and efficiency of coronar…

Many congratulations to Ziad Mallat a BHF Professor of Cardiovascular Medicine at the Victor Phillip Dahdaleh Heart and Lung Research Institute. Ziad has been awarded the Louis and Artur Lucian Award for Research in Circulatory Diseases due to his major contributions to cardiovascular immunology. The Louis and Artur Lucian Award was established thr…

Professors Ming Lei and Derek Terrar (Oxford University), Christopher Huang (University of Cambridge), and Lin Wu (Beijing University Hospital) have further developed their 2018 Oxford modernized antiarrhythmic drug (AAD) classification into a practical, more clinically useful, framework in a newly published (2025) article in Heart Rhythm, the offi…

Low-dose interleukin-2 induces clonal expansion of BACH2-repressed effector regulatory T cells following acute coronary syndromeTargeting inflammation in atherosclerotic cardiovascular disease remains a major unmet need. Low-dose interleukin-2 (IL-2LD) selectively increases regulatory T (Treg) cell numbers in patients with coronary artery disease.U…

Accumulating evidence indicates the important regulatory role of the adaptive immune system in atherosclerosis during all stages of the disease. The gut microbiome has also become a key regulator of atherosclerosis and immunomodulation.This review carried out by Dr Meritxell Nus, Dr Despoina Giakomidi and Ayoola Ishola explores potential strategies…

The history of SIYSS dates back to 1976 when the first seminar was organized by the Swedish Federation of Young Scientists, with inspiration from Society for Science & the Public in USA. Turning out to be a great success, the SIYSS program has continued, combining the encounter with Swedish science and the Nobel Prize Awarding Ceremonies.The partic…

Hyperlipidaemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Risk of cardiovascular events depends on cumulative lifetime exposure to low-density lipoprotein cholesterol (LDL-C) and, independently, on the time course of exposure to LDL-C, with early exposure being associated with a higher risk1. Furthermore, LDL-C fluct…